Trust staff to provide clinical guidance to tenants & across SBC network
Stevenage, UK, February 6 2017 – Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, and the East and North Hertfordshire NHS Trust are pleased to announce a clinical expertise partnership. Under this new relationship, physicians and other staff from the Trust will join SBC's Experts Panel and provide guidance on clinical matters to tenants. Other SBC activities, such as academic projects in the University laboratories and the DiscoverAssist drug discovery service, are also expected to benefit from this initiative.
The East and North Hertfordshire NHS Trust, which includes Hertford County Hospital, the Lister Hospital, Mount Vernon Cancer Centre and the New QEII Hospital, has major strengths in cancer, renal disease, cardiovascular disease, diabetes and robotic surgery. Associate Director of R&D, Dr Phillip Smith, has joined SBC's Experts Panel and will be invaluable in helping tenants carry out research in the NHS.
Martino Picardo, CEO of Stevenage Bioscience Catalyst, said, 'We welcome the East and North Hertfordshire NHS Trust to the SBC network and Experts Panel. The clinical guidance and access to NHS research capabilities it brings will be invaluable to our mission of creating impact through innovation.'
Phillip Smith, Associate Director of R&D at the Trust, added, 'Working with Stevenage Bioscience Catalyst is an exciting new initiative for the East and North Hertfordshire NHS Trust, and we are looking forward to helping it progress a range of projects and technologies. Relationships such as these are important in helping us deliver on our Research Strategy – 'Enhancing patient outcome and experience through research and innovation'.
Stevenage, UK, February 6 2017 – Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, and the East and North Hertfordshire NHS Trust are pleased to announce a clinical expertise partnership. Under this new relationship, physicians and other staff from the Trust will join SBC's Experts Panel and provide guidance on clinical matters to tenants. Other SBC activities, such as academic projects in the University laboratories and the DiscoverAssist drug discovery service, are also expected to benefit from this initiative.
The East and North Hertfordshire NHS Trust, which includes Hertford County Hospital, the Lister Hospital, Mount Vernon Cancer Centre and the New QEII Hospital, has major strengths in cancer, renal disease, cardiovascular disease, diabetes and robotic surgery. Associate Director of R&D, Dr Phillip Smith, has joined SBC's Experts Panel and will be invaluable in helping tenants carry out research in the NHS.
Martino Picardo, CEO of Stevenage Bioscience Catalyst, said, 'We welcome the East and North Hertfordshire NHS Trust to the SBC network and Experts Panel. The clinical guidance and access to NHS research capabilities it brings will be invaluable to our mission of creating impact through innovation.'
Phillip Smith, Associate Director of R&D at the Trust, added, 'Working with Stevenage Bioscience Catalyst is an exciting new initiative for the East and North Hertfordshire NHS Trust, and we are looking forward to helping it progress a range of projects and technologies. Relationships such as these are important in helping us deliver on our Research Strategy – 'Enhancing patient outcome and experience through research and innovation'.
